ABT: Abbott Laboratories Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ABT: Abbott Laboratories

ABT 124.25

-0.4%

11:57 AM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: HerbVic	9/2/2003 3:37:07 PM
	of 33

Biomed Rounds: Drug stories: A sneak preview of the fall lineup 09/02/2003 09:01 AM By Dyke Hendrickson Now that Labor Day has passed, revitalized life science types in the Hub are launching new projects, new companies, new stories. Like everyone else, Your Scribe has vowed to return to his tasks with renewed vigah. The following is one news story I plan for fall: Birth of a blockbuster — Your Scribe will be researching the history and development of Humira. This is a successful drug from Abbott Laboratories, the mammoth multinational with R&D facilities in Worcester. Humira is the most successful drug to have come to market in the past year. Designed to treat rheumatoid arthritis, it has racked up close to a half-billion dollars in sales in its first six months. <snip> masshightech.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next